vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and WEBSTER FINANCIAL CORP (WBS). Click either name above to swap in a different company.
WEBSTER FINANCIAL CORP is the larger business by last-quarter revenue ($735.9M vs $493.8M, roughly 1.5× Pediatrix Medical Group, Inc.). WEBSTER FINANCIAL CORP runs the higher net margin — 33.5% vs 6.8%, a 26.6% gap on every dollar of revenue. Over the past eight quarters, WEBSTER FINANCIAL CORP's revenue compounded faster (9.4% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Webster Bank is an American commercial bank based in Stamford, Connecticut. It has 177 branches and 316 ATMs located in Connecticut; Massachusetts; Rhode Island; New Jersey; Westchester, Orange, Ulster, and Rockland counties in New York as well as New York City.
MD vs WBS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $735.9M |
| Net Profit | $33.7M | $246.2M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | — |
| Net Margin | 6.8% | 33.5% |
| Revenue YoY | -1.7% | — |
| Net Profit YoY | 10.5% | 8.5% |
| EPS (diluted) | $0.40 | $1.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $735.9M | ||
| Q4 25 | $493.8M | $746.2M | ||
| Q3 25 | $492.9M | $732.6M | ||
| Q2 25 | $468.8M | $715.8M | ||
| Q1 25 | $458.4M | $704.8M | ||
| Q4 24 | $502.4M | $661.0M | ||
| Q3 24 | $511.2M | $647.6M | ||
| Q2 24 | $504.3M | $614.6M |
| Q1 26 | — | $246.2M | ||
| Q4 25 | $33.7M | $255.8M | ||
| Q3 25 | $71.7M | $261.2M | ||
| Q2 25 | $39.3M | $258.8M | ||
| Q1 25 | $20.7M | $226.9M | ||
| Q4 24 | $30.5M | $177.8M | ||
| Q3 24 | $19.4M | $193.0M | ||
| Q2 24 | $-153.0M | $181.6M |
| Q1 26 | — | — | ||
| Q4 25 | 9.9% | 48.6% | ||
| Q3 25 | 13.8% | 51.3% | ||
| Q2 25 | 12.8% | 51.7% | ||
| Q1 25 | 7.0% | 51.2% | ||
| Q4 24 | 7.8% | 48.5% | ||
| Q3 24 | 6.6% | 46.1% | ||
| Q2 24 | -31.3% | 47.0% |
| Q1 26 | — | 33.5% | ||
| Q4 25 | 6.8% | 34.3% | ||
| Q3 25 | 14.5% | 35.7% | ||
| Q2 25 | 8.4% | 36.2% | ||
| Q1 25 | 4.5% | 32.2% | ||
| Q4 24 | 6.1% | 26.9% | ||
| Q3 24 | 3.8% | 29.8% | ||
| Q2 24 | -30.3% | 29.6% |
| Q1 26 | — | $1.50 | ||
| Q4 25 | $0.40 | $1.54 | ||
| Q3 25 | $0.84 | $1.54 | ||
| Q2 25 | $0.46 | $1.52 | ||
| Q1 25 | $0.24 | $1.30 | ||
| Q4 24 | $0.37 | $1.01 | ||
| Q3 24 | $0.23 | $1.10 | ||
| Q2 24 | $-1.84 | $1.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | — |
| Total DebtLower is stronger | $570.5M | $738.3M |
| Stockholders' EquityBook value | $865.9M | $9.6B |
| Total Assets | $2.2B | $85.6B |
| Debt / EquityLower = less leverage | 0.66× | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $375.2M | — | ||
| Q3 25 | $340.1M | — | ||
| Q2 25 | $224.7M | — | ||
| Q1 25 | $99.0M | — | ||
| Q4 24 | $229.9M | — | ||
| Q3 24 | $103.8M | — | ||
| Q2 24 | $19.4M | — |
| Q1 26 | — | $738.3M | ||
| Q4 25 | $570.5M | $739.5M | ||
| Q3 25 | $577.2M | $1.2B | ||
| Q2 25 | $583.9M | $905.6M | ||
| Q1 25 | $590.5M | $907.4M | ||
| Q4 24 | $597.1M | $909.2M | ||
| Q3 24 | — | $911.0M | ||
| Q2 24 | — | $912.7M |
| Q1 26 | — | $9.6B | ||
| Q4 25 | $865.9M | $9.5B | ||
| Q3 25 | $890.7M | $9.5B | ||
| Q2 25 | $833.8M | $9.3B | ||
| Q1 25 | $789.2M | $9.2B | ||
| Q4 24 | $764.9M | $9.1B | ||
| Q3 24 | $732.5M | $9.2B | ||
| Q2 24 | $706.5M | $8.8B |
| Q1 26 | — | $85.6B | ||
| Q4 25 | $2.2B | $84.1B | ||
| Q3 25 | $2.2B | $83.2B | ||
| Q2 25 | $2.1B | $81.9B | ||
| Q1 25 | $2.0B | $80.3B | ||
| Q4 24 | $2.2B | $79.0B | ||
| Q3 24 | $2.1B | $79.5B | ||
| Q2 24 | $2.0B | $76.8B |
| Q1 26 | — | 0.08× | ||
| Q4 25 | 0.66× | 0.08× | ||
| Q3 25 | 0.65× | 0.13× | ||
| Q2 25 | 0.70× | 0.10× | ||
| Q1 25 | 0.75× | 0.10× | ||
| Q4 24 | 0.78× | 0.10× | ||
| Q3 24 | — | 0.10× | ||
| Q2 24 | — | 0.10× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $114.1M | $1.1B | ||
| Q3 25 | $137.3M | $374.7M | ||
| Q2 25 | $137.2M | $270.9M | ||
| Q1 25 | $-117.5M | $94.9M | ||
| Q4 24 | $133.0M | $1.4B | ||
| Q3 24 | $91.8M | $45.3M | ||
| Q2 24 | $107.0M | $224.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.0B | ||
| Q3 25 | — | $362.5M | ||
| Q2 25 | — | $257.7M | ||
| Q1 25 | — | $86.6M | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $35.3M | ||
| Q2 24 | — | $215.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 135.2% | ||
| Q3 25 | — | 49.5% | ||
| Q2 25 | — | 36.0% | ||
| Q1 25 | — | 12.3% | ||
| Q4 24 | — | 207.0% | ||
| Q3 24 | — | 5.4% | ||
| Q2 24 | — | 35.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 6.6% | ||
| Q3 25 | — | 1.7% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 5.4% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 1.4% |
| Q1 26 | — | — | ||
| Q4 25 | 3.39× | 4.14× | ||
| Q3 25 | 1.91× | 1.43× | ||
| Q2 25 | 3.49× | 1.05× | ||
| Q1 25 | -5.66× | 0.42× | ||
| Q4 24 | 4.36× | 7.90× | ||
| Q3 24 | 4.72× | 0.23× | ||
| Q2 24 | — | 1.23× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
WBS
| Net Interest Income | $634.4M | 86% |
| Noninterest Income | $101.5M | 14% |
